Flexion Therapeutics Inc

As a lean specialty pharmaceutical team, our goal is to cost effectively develop and commercialize novel therapies that will provide safe, substantial and sustained pain relief to the sufferers of musculoskeletal (MSK) diseases, the first of which is OA. We focus on product candidates that provide long-lasting analgesia locally while avoiding systemic side effects.